Article

Give Us Your Opinion

Give us your opinion on our latest poll, and see what your colleagues are saying. You can see the results of our previous surveys here as well.

Related Videos
Timothy Lyon, MD, answers a question during a video interview
Anne Pelletier Cameron, MD, FRCSC, FPMRS, answers a question during a video interview
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
1 expert is featured in this series.
Medcast series
Related Content
Incorporating mpMRI in bladder cancer staging may improve time to treatment
January 21st 2025

Incorporating mpMRI in bladder cancer staging may improve time to treatment

Hannah Clarke
The median time to correct treatment was 98 days with initial TURBT vs 53 days with initial mpMRI.
Episode 2 Podcast: Managing Overactive Bladder: From Dual Diagnoses to Geriatric Challenges
January 14th 2025

Episode 2 Podcast: Managing Overactive Bladder: From Dual Diagnoses to Geriatric Challenges

Wayne Kuang, MD Steven Maislos, MD
Panelists discuss how managing overactive bladder in older adults requires a holistic approach that integrates treatment of comorbidities, emerging therapeutic options, and quality-of-life considerations to optimize patient outcomes.
ROBUST I: Optilume maintains durable efficacy, safety for urethral strictures
January 20th 2025

ROBUST I: Optilume maintains durable efficacy, safety for urethral strictures

Hannah Clarke
Functional success was achieved in 58% of patients at 5-year follow-up.
Episode 1 Podcast: Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults
November 27th 2024

Episode 1 Podcast: Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults

Wayne Kuang, MD Bilal Chughtai, MD
Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.
Leveraging the full potential of APPs: Mark Edney, MD, on tips for successful collaboration
January 18th 2025

Leveraging the full potential of APPs: Mark Edney, MD, on tips for successful collaboration

Mark T. Edney, MD
"There are far more people presenting to us for care than we have people able to provide it. The APPs are going to be a critical part of trying to solve that puzzle," says Mark T. Edney, MD.
Enzalutamide included in next round of Medicare drug price negotiations
January 17th 2025

Enzalutamide included in next round of Medicare drug price negotiations

Hannah Clarke
The 15 drugs identified in this round of negotiations add to the 10 selected in the first round of negotiations that took place in 2023 and 2024.
© 2025 MJH Life Sciences

All rights reserved.